Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in Healthcare

Top Industry Players Attend BW Healthcare Summit In Delhi

Experts say India needs more financial investments and professional expertise to expand healthcare facilities across the country

Read More

Sun Pharma Q4 Net Up 93 Per Cent On Exclusivity Sales In US, Low cost

Sun Pharma’s formulation sales in the United States at $580 million during the quarter grew 19 per cent over the last year

Read More

St. Jude Medical To Launch HeartMate 3 Left Ventricular Assist System In India

The HeartMate 3 System offers physicians in India the most advanced ventricular assist technology available to support the management of patients with advanced stage heart failure

Read More

Aurobindo Pharma Fourth Quarter Profit Jumps 40%; Shares Rise 4%

The company's shares rose as much as 4 per cent to Rs 786.80 in early trade on Tuesday, while the broader market was down 0.15 per cent

Read More

India Approves First Stem Cell-based Drug For Buerger's Disease

The drug controller general of India has granted limited approval to Stempeutics Research, a joint venture between drug maker Cipla and Manipal Group for manufacturing and marketing its stem cell based biological drug Stempeucel for the treatment of Buerger’s Disease

Read More

Sun Pharma Gets US Subpoena Over Generic Drugs Pricing

The DoJ's antitrust division has also asked Sun Pharma's US unit for documents related to employee and corporate records and communications with competitors

Read More

How Not To Burn Yourself

Don’t eat roadside foods. Unless you trust the source, avoid fresh juices, junk foods like paani puri, cut fruits or salads outside

Read More

Dr Reddy's Acquires 6 OTC Brands From Ducere Of US

Dr Reddy's Laboratories said on Wednesday that it has acquired a range of consumer health or over-the-counter brands from the US-based Ducere Pharma Llc for an undisclosed sum

Read More

Analysts Cut Cipla 2017 Estimate After Weak Q4 Show

Cipla’s January-to-March quarter results were below the market expectation due to inventory write-offs or reductions, rationalisation of unviable geographies, higher research and development spends and regulatory costs

Read More

Ajanta Pharma Gets USFDA Approval Of Zolmitriptan Tablets

USFDA has granted Ajanta Pharma 9 ANDA final approvals and two tentative approvals. Additional 15 ANDAs are under review with the American regulator

Read More

Glenmark Gets US Approval For Banzel Generic With 6-Month Exclusivity

The company said it is eligible for 180 days of shared generic drug marketing exclusivity for rufinamide tablets

Read More

Lupin Fourth Quarter Profit Up 48%, Beats Estimates

Lupin has benefitted in recent months from a steady pace of new drug approvals in the United States at a time when most of its peers have been facing delays in getting approvals due to regulatory troubles

Read More

India Eyes Oil-For-Drugs Deal With Venezuela To Recoup Pharma Cash

Indian officials say they have proposed an oil-for-drugs barter plan with cash-strapped Venezuela to recoup millions of dollars in payments owed to some of India's largest pharmaceutical companies

Read More

Low Healthcare Expenditure Blights India

Dr Sanjiv Agarwal talks about how diabetes is growing in India with with changing lifestyles and affecting even children. He laments low public expenditure on health services

Read More

From Incurable To I’m Fine

The doctor of the future will give no medication, but will interest his patients in the care of the human frame, diet and in the cause and prevention of disease: Thomas Edison

Read More